Cyclopharm Ltd has released a press release.
USFDA Approval to File Received for Technegas
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Cyclopharm
- Technegas Approved in Russia
- USFDA Grants Cyclopharm USD$2.9m Application Fee Waiver
- Cyclopharm Lodges NDA for Technegas with the USFDA
- Cyclopharm Company Update
- CYC Institutional Placement - Premium To Share Price
Later from Cyclopharm
- CYC 1H2020 Business Update
- Technegas USA Trial Successfully Meets Primary Endpoint
- Cyclopharm Investor Presentation
- USFDA Approval Progress for Technegas and Business Update
- SNMMI Requests USFDA to Expedite Approval For Technegas
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm